Ryan W. Huey, MD, discusses challenges faced with immunotherapy in hepatocellular carcinoma.
Ryan W. Huey, MD
Advertisement
Articles by Ryan W. Huey, MD
Ryan W. Huey, MD, assistant professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses the landscape of hepatocellular carcinoma (HCC).
Ryan W. Huey, MD, discusses potential sequencing options with sorafenib among novel combination strategies in hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Huey on Challenges Faced With Immunotherapy in HCCPublished: June 20th 2020 | Updated:
Dr. Huey on Sequencing Sorafenib Among Novel Combos in HCCPublished: March 12th 2020 | Updated:
Dr. Huey on Navigating the Landscape of HCCPublished: April 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5